Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00387764 · BASELINE

Baseline characteristics

Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer · Source last updated 2014-01-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      80
    units
    Participants
groups
  1. description
    Participants received pazopanib 800 milligrams (mg) once daily.
    id
    BG000
    title
    Pazopanib 800 mg
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.95
          value
          60.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          19
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          61
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Central/South Asian Heritage (HER)
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Japanese/East Asian HER/South East Asian HER
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          68
      title
      White
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      80
    units
    Participants
groups
  1. description
    Participants received pazopanib 800 milligrams (mg) once daily.
    id
    BG000
    title
    Pazopanib 800 mg
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.95
          value
          60.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          19
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          61
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Central/South Asian Heritage (HER)
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Japanese/East Asian HER/South East Asian HER
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          68
      title
      White
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice